FMR LLC - 25 Jun 2026 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Reporting relationship: Other*, 10%+ Owner
Issuer ticker: BEAM
Reported as of: 25 Jun 2026
Net transaction value: -$10,039,492
SEC form: 4
Accepted by SEC: 29 Jun 2026, 14:17:18 UTC
Prior SEC filing: 05 May 2026
Next SEC filing: 24 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson

Key filing fact

FMR LLC filed Form 4 for Beam Therapeutics Inc. (BEAM) on 29 Jun 2026.

Key facts

This page summarizes FMR LLC's Form 4 filing for Beam Therapeutics Inc. (BEAM).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 29 Jun 2026, 14:17.

Change

Previous filing in this sequence was filed on 05 May 2026.
Current net transaction value: -$10,039,492.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000315066 Primary reporting owner

FMR LLC

Relationship: Other*, 10%+ Owner
Address: 245 SUMMER STREET, BOSTON
Signature: /s/ Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
Signature date: 29 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BEAM transaction

Common Stock

Sale

Transaction value: $1,172,025
Shares: -33,372
Change %: -2.9%
Price: $35.12
Shares after: 1,106,071
Date: 25 Jun 2026
Ownership: F-Prime Capital Partners Healthcare Fund V LP
Footnotes: F1

BEAM transaction

Common Stock

Sale

Transaction value: $8,867,467
Shares: -251,488
Change %: -23%
Price: $35.26
Shares after: 854,583
Date: 26 Jun 2026
Ownership: F-Prime Capital Partners Healthcare Fund V LP
Footnotes: F2

BEAM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14
Date: 25 Jun 2026
Ownership: FMR Capital, Inc.

BEAM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 841,231
Date: 25 Jun 2026
Ownership: Shares held by persons and entities whose shares are subject to reporting by the undersigned.

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $35.00 to $35.39. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information.

Footnote F2

The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $35.00 to $35.88. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information.

SEC remarks

Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Remark 3: The general partner of F-Prime Capital Partners Healthcare Fund V LP is F-Prime Capital Partners Healthcare Advisors Fund V LP (FPCPHA). FPCPHA is solely managed by Impresa Management LLC, the managing member of its general partner and its investment manager. FMR Capital, Inc. is a wholly owned subsidiary of FMR LLC.